{
    "2018-04-27": [
        [
            {
                "time": "",
                "original_text": "复星医药：一季度净利润同比减4.33%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "一季度",
                        "净利润",
                        "同比减少"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-27",
                "original_text": "0427涨停股揭秘：永安药业引领医药板块大涨",
                "features": {
                    "keywords": [
                        "永安药业",
                        "涨停",
                        "医药板块",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-27",
                "original_text": "中证数据：两市资金净流入前20股（4月27日）",
                "features": {
                    "keywords": [
                        "两市",
                        "资金净流入",
                        "前20股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "慧聪集团喜获最受内地机构投资者关注港股通公司荣誉",
                "features": {
                    "keywords": [
                        "慧聪集团",
                        "内地机构投资者",
                        "港股通",
                        "荣誉"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-04-27",
                "original_text": "0427午间资讯汇总：华锋股份复牌再封涨停",
                "features": {
                    "keywords": [
                        "华锋股份",
                        "复牌",
                        "涨停"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中投证券：动荡之中建议关注医药生物细分领域龙头白马",
                "features": {
                    "keywords": [
                        "中投证券",
                        "动荡",
                        "医药生物",
                        "细分领域",
                        "龙头白马"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "多项单抗类生物药进入三期临床",
                "features": {
                    "keywords": [
                        "单抗类生物药",
                        "三期临床"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "部分白马股现业绩地雷 昔日牛股今失蹄",
                "features": {
                    "keywords": [
                        "白马股",
                        "业绩地雷",
                        "牛股",
                        "失蹄"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：关注三大领域投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三大领域",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:关注一季报优异个股及商业板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一季报",
                        "优异个股",
                        "商业板块"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}